According to Core Scientific's latest financial reports the company has S$1.11 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | S$1.13 B | 1607.27% |
2023-12-31 | S$66.57 M | 212.65% |
2022-12-31 | S$21.29 M | -86.64% |
2021-12-31 | S$0.15 B | 1289.14% |
2020-12-31 | S$11.47 M | 27.82% |
2019-12-31 | S$8.97 M |